Selective Destruction of Interleukin 23–Induced Expansion of a Major Antigen–Specific γδ T-Cell Subset in Patients With Tuberculosis

A loss of antigen-specific T-cell responses due to defective cytokine signaling during infections has not been reported. We hypothesize that tuberculosis can destroy signaling effects of selective cytokine(s) and induce exhaustion of antigen-specific T cells. To test this hypothesis, mechanistic stu...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 215; no. 3; pp. 420 - 430
Main Authors Shen, Hongbo, Gu, Jin, Xiao, Heping, Liang, Shanshan, Yang, Enzhuo, Yang, Rui, Huang, Dan, Chen, Crystal, Wang, Feifei, Shen, Ling, Chen, Zheng W.
Format Journal Article
LanguageEnglish
Published United States Oxford University Press 01.02.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A loss of antigen-specific T-cell responses due to defective cytokine signaling during infections has not been reported. We hypothesize that tuberculosis can destroy signaling effects of selective cytokine(s) and induce exhaustion of antigen-specific T cells. To test this hypothesis, mechanistic studies were performed to examine whether and how tuberculosis blocked interleukin 23 (IL-23) and interleukin 2 (IL-2) signaling effects on a major human γδ T-cell subpopulation, phosphoantigen HMBPP–specific Vγ2Vδ2 T cells. IL-23 and IL-2 significantly expanded HMBPP-stimulated Vγ2Vδ2 T cells from subjects with latent tuberculosis infection, and IL-2 synergized the effect of IL-23. IL-23–induced expansion of Vγ2Vδ2 T cells involved STAT3. Surprisingly, patients with tuberculosis exhibited a selective destruction of IL-23–induced expansion of these cells. The tuberculosis-driven destruction of IL-23 signaling coincided with decreases of expression and phosphorylation of STAT3. Interestingly, impairing of STAT3 was linked to marked increases in the microRNAs (miRNAs) hsa-miR-337-3p and hsa-miR-125b-5p in Vγ2Vδ2 T cells from patients with tuberculosis. Downregulation of hsa-miR-337-3p and hsa-miR-125b-5p by miRNA sponges improved IL-23–mediated expansion of Vγ2Vδ2 T cells and restored the ability of these cells to produce anti-tuberculosis cytokines. These results support our hypothesis that tuberculosis can selectively impair a cytokine effect while sparing another and can induce exhaustion of T cells in response to the respective cytokine.
AbstractList A loss of antigen-specific T-cell responses due to defective cytokine signaling during infections has not been reported. We hypothesize that tuberculosis can destroy signaling effects of selective cytokine(s) and induce exhaustion of antigen-specific T cells. To test this hypothesis, mechanistic studies were performed to examine whether and how tuberculosis blocked interleukin 23 (IL-23) and interleukin 2 (IL-2) signaling effects on a major human γδ T-cell subpopulation, phosphoantigen HMBPP-specific Vγ2Vδ2 T cells. IL-23 and IL-2 significantly expanded HMBPP-stimulated Vγ2Vδ2 T cells from subjects with latent tuberculosis infection, and IL-2 synergized the effect of IL-23. IL-23-induced expansion of Vγ2Vδ2 T cells involved STAT3. Surprisingly, patients with tuberculosis exhibited a selective destruction of IL-23-induced expansion of these cells. The tuberculosis-driven destruction of IL-23 signaling coincided with decreases of expression and phosphorylation of STAT3. Interestingly, impairing of STAT3 was linked to marked increases in the microRNAs (miRNAs) hsa-miR-337-3p and hsa-miR-125b-5p in Vγ2Vδ2 T cells from patients with tuberculosis. Downregulation of hsa-miR-337-3p and hsa-miR-125b-5p by miRNA sponges improved IL-23-mediated expansion of Vγ2Vδ2 T cells and restored the ability of these cells to produce anti-tuberculosis cytokines. These results support our hypothesis that tuberculosis can selectively impair a cytokine effect while sparing another and can induce exhaustion of T cells in response to the respective cytokine.A loss of antigen-specific T-cell responses due to defective cytokine signaling during infections has not been reported. We hypothesize that tuberculosis can destroy signaling effects of selective cytokine(s) and induce exhaustion of antigen-specific T cells. To test this hypothesis, mechanistic studies were performed to examine whether and how tuberculosis blocked interleukin 23 (IL-23) and interleukin 2 (IL-2) signaling effects on a major human γδ T-cell subpopulation, phosphoantigen HMBPP-specific Vγ2Vδ2 T cells. IL-23 and IL-2 significantly expanded HMBPP-stimulated Vγ2Vδ2 T cells from subjects with latent tuberculosis infection, and IL-2 synergized the effect of IL-23. IL-23-induced expansion of Vγ2Vδ2 T cells involved STAT3. Surprisingly, patients with tuberculosis exhibited a selective destruction of IL-23-induced expansion of these cells. The tuberculosis-driven destruction of IL-23 signaling coincided with decreases of expression and phosphorylation of STAT3. Interestingly, impairing of STAT3 was linked to marked increases in the microRNAs (miRNAs) hsa-miR-337-3p and hsa-miR-125b-5p in Vγ2Vδ2 T cells from patients with tuberculosis. Downregulation of hsa-miR-337-3p and hsa-miR-125b-5p by miRNA sponges improved IL-23-mediated expansion of Vγ2Vδ2 T cells and restored the ability of these cells to produce anti-tuberculosis cytokines. These results support our hypothesis that tuberculosis can selectively impair a cytokine effect while sparing another and can induce exhaustion of T cells in response to the respective cytokine.
Abstract A loss of antigen-specific T-cell responses due to defective cytokine signaling during infections has not been reported. We hypothesize that tuberculosis can destroy signaling effects of selective cytokine(s) and induce exhaustion of antigen-specific T cells. To test this hypothesis, mechanistic studies were performed to examine whether and how tuberculosis blocked interleukin 23 (IL-23) and interleukin 2 (IL-2) signaling effects on a major human γδ T-cell subpopulation, phosphoantigen HMBPP–specific Vγ2Vδ2 T cells. IL-23 and IL-2 significantly expanded HMBPP-stimulated Vγ2Vδ2 T cells from subjects with latent tuberculosis infection, and IL-2 synergized the effect of IL-23. IL-23–induced expansion of Vγ2Vδ2 T cells involved STAT3. Surprisingly, patients with tuberculosis exhibited a selective destruction of IL-23–induced expansion of these cells. The tuberculosis-driven destruction of IL-23 signaling coincided with decreases of expression and phosphorylation of STAT3. Interestingly, impairing of STAT3 was linked to marked increases in the microRNAs (miRNAs) hsa-miR-337-3p and hsa-miR-125b-5p in Vγ2Vδ2 T cells from patients with tuberculosis. Downregulation of hsa-miR-337-3p and hsa-miR-125b-5p by miRNA sponges improved IL-23–mediated expansion of Vγ2Vδ2 T cells and restored the ability of these cells to produce anti–tuberculosis cytokines. These results support our hypothesis that tuberculosis can selectively impair a cytokine effect while sparing another and can induce exhaustion of T cells in response to the respective cytokine.
A loss of antigen-specific T-cell responses due to defective cytokine signaling during infections has not been reported. We hypothesize that tuberculosis can destroy signaling effects of selective cytokine(s) and induce exhaustion of antigen-specific T cells. To test this hypothesis, mechanistic studies were performed to examine whether and how tuberculosis blocked interleukin 23 (IL-23) and interleukin 2 (IL-2) signaling effects on a major human γδ T-cell subpopulation, phosphoantigen HMBPP-specific Vγ2Vδ2 T cells. IL-23 and IL-2 significantly expanded HMBPP-stimulated Vγ2Vδ2 T cells from subjects with latent tuberculosis infection, and IL-2 synergized the effect of IL-23. IL-23-induced expansion of Vγ2Vδ2 T cells involved STAT3. Surprisingly, patients with tuberculosis exhibited a selective destruction of IL-23-induced expansion of these cells. The tuberculosis-driven destruction of IL-23 signaling coincided with decreases of expression and phosphorylation of STAT3. Interestingly, impairing of STAT3 was linked to marked increases in the microRNAs (miRNAs) hsa-miR-337-3p and hsa-miR-125b-5p in Vγ2Vδ2 T cells from patients with tuberculosis. Downregulation of hsa-miR-337-3p and hsa-miR-125b-5p by miRNA sponges improved IL-23-mediated expansion of Vγ2Vδ2 T cells and restored the ability of these cells to produce anti-tuberculosis cytokines. These results support our hypothesis that tuberculosis can selectively impair a cytokine effect while sparing another and can induce exhaustion of T cells in response to the respective cytokine.
Author Gu, Jin
Yang, Enzhuo
Chen, Crystal
Shen, Hongbo
Shen, Ling
Yang, Rui
Wang, Feifei
Xiao, Heping
Huang, Dan
Chen, Zheng W.
Liang, Shanshan
AuthorAffiliation 4 Department of Microbiology and Immunology
6 Institut Pasteur of Shanghai, China
5 Center for Primate Biomedical Research , University of Illinois College of Medicine , Chicago
1 Unit of Antituberculosis Immunity, CAS Key Laboratory of Molecular Virology and Immunology , Institut Pasteur of Shanghai, Chinese Academy of Sciences
3 Department of Medical Microbiology and Parasitology , Shanghai Medical College, Fudan University , Shanghai , China
2 Clinic and Research Center of Tuberculosis, Shanghai Key Lab of Tuberculosis , Shanghai Pulmonary Hospital , Tongji University School of Medicine
AuthorAffiliation_xml – name: 2 Clinic and Research Center of Tuberculosis, Shanghai Key Lab of Tuberculosis , Shanghai Pulmonary Hospital , Tongji University School of Medicine
– name: 5 Center for Primate Biomedical Research , University of Illinois College of Medicine , Chicago
– name: 1 Unit of Antituberculosis Immunity, CAS Key Laboratory of Molecular Virology and Immunology , Institut Pasteur of Shanghai, Chinese Academy of Sciences
– name: 3 Department of Medical Microbiology and Parasitology , Shanghai Medical College, Fudan University , Shanghai , China
– name: 6 Institut Pasteur of Shanghai, China
– name: 4 Department of Microbiology and Immunology
Author_xml – sequence: 1
  givenname: Hongbo
  surname: Shen
  fullname: Shen, Hongbo
– sequence: 2
  givenname: Jin
  surname: Gu
  fullname: Gu, Jin
– sequence: 3
  givenname: Heping
  surname: Xiao
  fullname: Xiao, Heping
– sequence: 4
  givenname: Shanshan
  surname: Liang
  fullname: Liang, Shanshan
– sequence: 5
  givenname: Enzhuo
  surname: Yang
  fullname: Yang, Enzhuo
– sequence: 6
  givenname: Rui
  surname: Yang
  fullname: Yang, Rui
– sequence: 7
  givenname: Dan
  surname: Huang
  fullname: Huang, Dan
– sequence: 8
  givenname: Crystal
  surname: Chen
  fullname: Chen, Crystal
– sequence: 9
  givenname: Feifei
  surname: Wang
  fullname: Wang, Feifei
– sequence: 10
  givenname: Ling
  surname: Shen
  fullname: Shen, Ling
– sequence: 11
  givenname: Zheng W.
  surname: Chen
  fullname: Chen, Zheng W.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27789724$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1u1DAUhS1URKeFJUuQl2xC_ZPEyQapGgqMVATSDGJpOc5N6yFjD_4psGPNlkeB5-hD8CS4ZCg_EmJlS_58zrn3HKA96ywgdJeSh5S0_MjYoTfhaG3eVZTeQDNacVHUNeV7aEYIYwVt2nYfHYSwJoSUvBa30D4TomkFK2fo0xJG0NFcAH4MIfqU785iN-CFjeBHSG-MxYx_-_h5Yfukoccn77fKhh2l8HO1dh4f22jOwGZsuQVtBqPx5ZfLr3hVzGEc8TJ1ASLOUi9VNGBjwK9NPMer1IHXaXTBhNvo5qDGAHd25yF69eRkNX9WnL54upgfnxaaV4IWoGjPB6VZyRpVdgyE0FXPgA601eVQtoMqG6E1ENZq3tEG-k5QTupaEKoV44fo0aS7Td0Gep3TeDXKrTcb5T9Ip4z888Wac3nmLmTVVJw3JAs82Al49zblrcmNCTqPqSy4FCRteFW3rCQio_d_97o2-VlABooJ0N6F4GG4RiiRVwXLqWA5FZx5_hevTVRXneWoZvznr11il7b_Nbg3oesQnf8VuKY_Fsi_A-iGypw
CitedBy_id crossref_primary_10_1128_IAI_00315_21
crossref_primary_10_3389_fcimb_2021_669394
crossref_primary_10_1021_acsomega_4c07053
crossref_primary_10_3389_fmicb_2023_1236012
crossref_primary_10_3389_fimmu_2021_739219
crossref_primary_10_3389_fimmu_2024_1469118
crossref_primary_10_3389_fimmu_2021_599641
crossref_primary_10_1007_s12088_024_01227_4
crossref_primary_10_1089_jir_2023_0007
crossref_primary_10_3389_fimmu_2022_987018
Cites_doi 10.1002/eji.201444635
10.4049/jimmunol.178.7.4304
10.1084/jem.20132577
10.1084/jem.190.9.1297
10.1086/592448
10.1086/345766
10.1016/j.fct.2013.11.040
10.1182/blood-2008-06-162792
10.1016/j.immuni.2007.11.016
10.1038/cmi.2012.46
10.1016/j.immuni.2010.09.015
10.1002/stem.1609
10.1016/j.cellimm.2013.05.001
10.3324/haematol.2008.002352
10.1016/j.coi.2005.11.007
10.1073/pnas.0811250106
10.1073/pnas.1007394107
10.1093/infdis/173.5.1267
10.1111/j.1365-2567.2007.02766.x
10.1371/journal.ppat.1002984
10.4049/jimmunol.1102609
10.1371/journal.pone.0136476
10.1126/science.8140422
10.1089/jir.2010.0083
10.1126/science.1168676
10.1002/eji.201343680
10.1128/MMBR.00010-14
10.1016/j.immuni.2011.12.015
10.3109/07357907.2014.883526
10.1016/S0092-8674(01)00616-X
10.1126/science.1068819
10.1093/infdis/jit206
10.1128/JVI.06000-11
10.1111/j.1744-313X.2012.01084.x
10.1111/j.1365-2443.2010.01474.x
10.1016/j.cell.2015.08.052
10.1016/j.jhep.2014.07.005
10.1016/j.cellimm.2014.11.001
10.1152/physiolgenomics.00122.2013
10.4049/jimmunol.1101291
10.1016/S1471-4906(03)00032-2
10.1158/2326-6066.CIR-14-0201
ContentType Journal Article
Copyright Copyright © 2017 Oxford University Press on behalf of the Infectious Diseases Society of America
The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2016
The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Copyright_xml – notice: Copyright © 2017 Oxford University Press on behalf of the Infectious Diseases Society of America
– notice: The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2016
– notice: The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1093/infdis/jiw511
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1537-6613
EndPage 430
ExternalDocumentID PMC5853380
27789724
10_1093_infdis_jiw511
10.1093/infdis/jiw511
26166701
Genre Journal Article
GrantInformation_xml – fundername: the Chinese National Major Projects
  grantid: 2013ZX10003009-002
– fundername: National Institutes of Health
  grantid: R01 HL64560/OD015092/HL129887
  funderid: 10.13039/100000002
– fundername: NHLBI NIH HHS
  grantid: R01 HL064560
– fundername: NCRR NIH HHS
  grantid: R01 RR013601
– fundername: NIH HHS
  grantid: R01 OD015092
– fundername: NHLBI NIH HHS
  grantid: R01 HL129887
– fundername: ; ; ;
  grantid: R01 HL64560/OD015092/HL129887
– fundername: ; ;
  grantid: 2013ZX10003009-002
GroupedDBID ---
-DZ
-~X
..I
.2P
.I3
.XZ
.ZR
08P
0R~
123
1KJ
1TH
29K
2AX
2WC
36B
4.4
48X
53G
5GY
5RE
5VS
5WD
70D
85S
AABZA
AACGO
AACZT
AAHBH
AAHTB
AAJKP
AAJQQ
AAMVS
AANCE
AAOGV
AAPNW
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAUQX
AAVAP
AAWTL
ABBHK
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABLJU
ABNHQ
ABNKS
ABOCM
ABPEJ
ABPLY
ABPPZ
ABPQP
ABPTD
ABQLI
ABQNK
ABTLG
ABVGC
ABWST
ABXSQ
ABXVV
ABZBJ
ACGFO
ACGFS
ACGOD
ACHIC
ACPRK
ACUFI
ACUTJ
ACUTO
ACYHN
ADBBV
ADEYI
ADGZP
ADHKW
ADHZD
ADIPN
ADNBA
ADOCK
ADQBN
ADQXQ
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEUPB
AEWNT
AEXZC
AFFZL
AFIYH
AFOFC
AFXAL
AFYAG
AGINJ
AGKEF
AGORE
AGQXC
AGSYK
AGUTN
AHMBA
AHMMS
AHXPO
AIAGR
AIJHB
AJBYB
AJEEA
AJNCP
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APWMN
AQVQM
ATGXG
AXUDD
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BR6
BTRTY
BVRKM
C45
CDBKE
CS3
CZ4
D-I
DAKXR
DCCCD
DIK
DILTD
DU5
D~K
EBS
ECGQY
EE~
EJD
EMOBN
ENERS
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HW0
HZ~
IH2
IOX
IPSME
J21
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JST
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
LSO
LU7
MHKGH
MJL
ML0
N9A
NGC
NOMLY
NOYVH
NU-
NVLIB
O9-
OAUYM
OAWHX
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
QBD
RD5
ROX
ROZ
RUSNO
RW1
RXO
SA0
SJN
TCURE
TEORI
TJX
TR2
W2D
W8F
WH7
X7H
YAYTL
YKOAZ
YXANX
~91
AASNB
ADACV
ADJQC
ADRIX
AFXEN
DOOOF
ESX
M49
ZKG
AAYXX
ADULT
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c3571-ea1d3fac2428a4b2e77c5d2e1f19c4f49fa487cce029c3b18edb713066701ca23
ISSN 0022-1899
1537-6613
IngestDate Thu Aug 21 18:42:16 EDT 2025
Fri Jul 11 04:29:08 EDT 2025
Thu Apr 03 06:49:15 EDT 2025
Thu Apr 24 23:06:13 EDT 2025
Tue Jul 01 01:31:04 EDT 2025
Wed Sep 11 04:48:10 EDT 2024
Thu Jun 19 22:20:43 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Vγ2Vδ2 T cells
cytokine signaling
JAK2/STAT3
miRNA
T-cell exhaustion
tuberculosis
Language English
License The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3571-ea1d3fac2428a4b2e77c5d2e1f19c4f49fa487cce029c3b18edb713066701ca23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
H. S., J. G. and H. X. contributed equally to this work and are co–first authors.
Correspondence: H. Shen, Institute of Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China (hbshen@ips.ac.cn).
OpenAccessLink https://academic.oup.com/jid/article-pdf/215/3/420/24262071/jiw511.pdf
PMID 27789724
PQID 1835692407
PQPubID 23479
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5853380
proquest_miscellaneous_1835692407
pubmed_primary_27789724
crossref_primary_10_1093_infdis_jiw511
crossref_citationtrail_10_1093_infdis_jiw511
oup_primary_10_1093_infdis_jiw511
jstor_primary_26166701
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-Feb-01
PublicationDateYYYYMMDD 2017-02-01
PublicationDate_xml – month: 02
  year: 2017
  text: 2017-Feb-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of infectious diseases
PublicationTitleAlternate J Infect Dis
PublicationYear 2017
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References Bonneville (2017011017160979000_jiw511v2.16) 2015; 296
2017011017160979000_jiw511v2.2
2017011017160979000_jiw511v2.3
2017011017160979000_jiw511v2.1
Liu (2017011017160979000_jiw511v2.36) 2015; S0171-2985
2017011017160979000_jiw511v2.6
2017011017160979000_jiw511v2.13
2017011017160979000_jiw511v2.35
2017011017160979000_jiw511v2.7
2017011017160979000_jiw511v2.14
2017011017160979000_jiw511v2.4
2017011017160979000_jiw511v2.11
2017011017160979000_jiw511v2.33
2017011017160979000_jiw511v2.5
2017011017160979000_jiw511v2.12
2017011017160979000_jiw511v2.31
2017011017160979000_jiw511v2.10
2017011017160979000_jiw511v2.32
2017011017160979000_jiw511v2.8
2017011017160979000_jiw511v2.9
2017011017160979000_jiw511v2.30
2017011017160979000_jiw511v2.19
2017011017160979000_jiw511v2.17
2017011017160979000_jiw511v2.39
2017011017160979000_jiw511v2.15
2017011017160979000_jiw511v2.37
2017011017160979000_jiw511v2.38
Daker (2017011017160979000_jiw511v2.20) 2013; 282
Shen (2017011017160979000_jiw511v2.18) 2015; 45
Chen (2017011017160979000_jiw511v2.22) 2012; 199
2017011017160979000_jiw511v2.24
2017011017160979000_jiw511v2.25
Valle-Mendiola (2017011017160979000_jiw511v2.42) 2014; 32
2017011017160979000_jiw511v2.44
2017011017160979000_jiw511v2.23
2017011017160979000_jiw511v2.21
2017011017160979000_jiw511v2.43
2017011017160979000_jiw511v2.40
2017011017160979000_jiw511v2.41
2017011017160979000_jiw511v2.28
2017011017160979000_jiw511v2.29
2017011017160979000_jiw511v2.26
2017011017160979000_jiw511v2.27
Seo (2017011017160979000_jiw511v2.34) 2014; 64
21138378 - J Interferon Cytokine Res. 2011 Apr;31(4):363-71
19383786 - Proc Natl Acad Sci U S A. 2009 May 5;106(18):7553-8
8627084 - J Infect Dis. 1996 May;173(5):1267-72
24548303 - Cancer Invest. 2014 May;32(4):115-25
23770719 - Cell Immunol. 2013 Apr;282(2):106-12
23147720 - Cell Mol Immunol. 2013 Jan;10(1):58-64
22269120 - Int J Immunogenet. 2012 Jun;39(3):247-52
22422881 - J Immunol. 2012 Apr 15;188(8):3745-56
19325114 - Science. 2009 Mar 27;323(5922):1726-9
22258246 - J Virol. 2012 Apr;86(8):4213-21
25184558 - Microbiol Mol Biol Rev. 2014 Sep;78(3):343-71
16337364 - Curr Opin Immunol. 2006 Feb;18(1):31-8
21155952 - Genes Cells. 2011 Feb;16(2):179-89
24192393 - Physiol Genomics. 2013 Dec 15;45(24):1206-14
23144609 - PLoS Pathog. 2012;8(11):e1002984
25016223 - J Hepatol. 2014 Dec;61(6):1212-9
19229050 - Haematologica. 2009 Apr;94(4):576-80
22474020 - J Immunol. 2012 May 1;188(9):4278-88
25141829 - Eur J Immunol. 2015 Feb;45(2):442-51
26361042 - PLoS One. 2015 Sep 11;10(9):e0136476
11910108 - Science. 2002 Mar 22;295(5563):2255-8
25113973 - J Exp Med. 2014 Aug 25;211(9):1905-18
12697454 - Trends Immunol. 2003 Apr;24(4):213-9
24643836 - Eur J Immunol. 2014 Jul;44(7):2013-24
26359984 - Cell. 2015 Sep 10;162(6):1242-56
18811584 - J Infect Dis. 2008 Nov 15;198(10):1514-9
18981295 - Blood. 2009 Jan 22;113(4):837-45
8140422 - Science. 1994 Apr 1;264(5155):95-8
20624978 - Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13402-7
21029966 - Immunity. 2010 Oct 29;33(4):567-77
17371987 - J Immunol. 2007 Apr 1;178(7):4304-14
18164222 - Immunity. 2008 Jan;28(1):29-39
25701326 - Cancer Immunol Res. 2015 Jun;3(6):620-30
22342841 - Immunity. 2012 Feb 24;36(2):239-50
24302476 - Stem Cells. 2014 May;32(5):1149-60
11779458 - Cell. 2001 Dec 28;107(7):823-6
25468804 - Cell Immunol. 2015 Jul;296(1):3-9
10544201 - J Exp Med. 1999 Nov 1;190(9):1297-308
23661793 - J Infect Dis. 2013 Aug 15;208(4):603-15
24316209 - Food Chem Toxicol. 2014 Feb;64:217-24
25720636 - Immunobiology. 2015 Aug;220(8):947-53
18266718 - Immunology. 2008 Jun;124(2):277-93
12447771 - J Infect Dis. 2002 Dec 15;186(12):1835-9
References_xml – volume: 45
  start-page: 442
  year: 2015
  ident: 2017011017160979000_jiw511v2.18
  article-title: Th17-related cytokines contribute to recall-like expansion/effector function of HMBPP-specific Vγ2Vδ2T cells after M. tuberculosis infection or vaccination
  publication-title: . Eur J Immunol
  doi: 10.1002/eji.201444635
– ident: 2017011017160979000_jiw511v2.17
  doi: 10.4049/jimmunol.178.7.4304
– ident: 2017011017160979000_jiw511v2.1
  doi: 10.1084/jem.20132577
– ident: 2017011017160979000_jiw511v2.27
  doi: 10.1084/jem.190.9.1297
– ident: 2017011017160979000_jiw511v2.41
  doi: 10.1086/592448
– ident: 2017011017160979000_jiw511v2.21
  doi: 10.1086/345766
– volume: 64
  start-page: 217
  year: 2014
  ident: 2017011017160979000_jiw511v2.34
  article-title: Cucurbitacin B and cucurbitacin I suppress adipocyte differentiation through inhibition of STAT3 signaling
  publication-title: Food Chem Toxicol
  doi: 10.1016/j.fct.2013.11.040
– ident: 2017011017160979000_jiw511v2.25
  doi: 10.1182/blood-2008-06-162792
– ident: 2017011017160979000_jiw511v2.28
  doi: 10.1016/j.immuni.2007.11.016
– ident: 2017011017160979000_jiw511v2.9
  doi: 10.1038/cmi.2012.46
– ident: 2017011017160979000_jiw511v2.8
  doi: 10.1016/j.immuni.2010.09.015
– ident: 2017011017160979000_jiw511v2.31
  doi: 10.1002/stem.1609
– volume: 282
  start-page: 106
  year: 2013
  ident: 2017011017160979000_jiw511v2.20
  article-title: An abnormal phenotype of lung Vγ9Vδ2 T cells impairs their responsiveness in tuberculosis patients
  publication-title: Cell Immunol
  doi: 10.1016/j.cellimm.2013.05.001
– ident: 2017011017160979000_jiw511v2.37
  doi: 10.3324/haematol.2008.002352
– ident: 2017011017160979000_jiw511v2.14
  doi: 10.1016/j.coi.2005.11.007
– ident: 2017011017160979000_jiw511v2.26
  doi: 10.1073/pnas.0811250106
– ident: 2017011017160979000_jiw511v2.10
  doi: 10.1073/pnas.1007394107
– ident: 2017011017160979000_jiw511v2.19
  doi: 10.1093/infdis/173.5.1267
– ident: 2017011017160979000_jiw511v2.23
  doi: 10.1111/j.1365-2567.2007.02766.x
– ident: 2017011017160979000_jiw511v2.3
  doi: 10.1371/journal.ppat.1002984
– ident: 2017011017160979000_jiw511v2.11
  doi: 10.4049/jimmunol.1102609
– ident: 2017011017160979000_jiw511v2.43
  doi: 10.1371/journal.pone.0136476
– ident: 2017011017160979000_jiw511v2.32
  doi: 10.1126/science.8140422
– ident: 2017011017160979000_jiw511v2.44
  doi: 10.1089/jir.2010.0083
– ident: 2017011017160979000_jiw511v2.5
  doi: 10.1126/science.1168676
– ident: 2017011017160979000_jiw511v2.29
  doi: 10.1002/eji.201343680
– ident: 2017011017160979000_jiw511v2.7
  doi: 10.1128/MMBR.00010-14
– ident: 2017011017160979000_jiw511v2.40
  doi: 10.1016/j.immuni.2011.12.015
– volume: 32
  start-page: 115
  year: 2014
  ident: 2017011017160979000_jiw511v2.42
  article-title: IL-2 enhances cervical cancer cells proliferation and JAK3/STAT5 phosphorylation at low doses, while at high doses IL-2 has opposite effects
  publication-title: Cancer Invest
  doi: 10.3109/07357907.2014.883526
– ident: 2017011017160979000_jiw511v2.38
  doi: 10.1016/S0092-8674(01)00616-X
– ident: 2017011017160979000_jiw511v2.15
  doi: 10.1126/science.1068819
– ident: 2017011017160979000_jiw511v2.12
  doi: 10.1093/infdis/jit206
– volume: S0171-2985
  start-page: 00025
  year: 2015
  ident: 2017011017160979000_jiw511v2.36
  article-title: SOCS3 promotes inflammation and apoptosis via inhibiting JAK2/STAT3 signaling pathway in 3T3-L1 adipocyte
  publication-title: Immunobiology
– ident: 2017011017160979000_jiw511v2.24
  doi: 10.1128/JVI.06000-11
– ident: 2017011017160979000_jiw511v2.33
  doi: 10.1111/j.1744-313X.2012.01084.x
– ident: 2017011017160979000_jiw511v2.35
  doi: 10.1111/j.1365-2443.2010.01474.x
– ident: 2017011017160979000_jiw511v2.4
  doi: 10.1016/j.cell.2015.08.052
– ident: 2017011017160979000_jiw511v2.30
  doi: 10.1016/j.jhep.2014.07.005
– ident: 2017011017160979000_jiw511v2.6
– volume: 296
  start-page: 3
  year: 2015
  ident: 2017011017160979000_jiw511v2.16
  article-title: Chicago 2014—30 years of γδ T cells
  publication-title: Cell Immunol
  doi: 10.1016/j.cellimm.2014.11.001
– ident: 2017011017160979000_jiw511v2.39
  doi: 10.1152/physiolgenomics.00122.2013
– volume: 199
  start-page: 4278
  year: 2012
  ident: 2017011017160979000_jiw511v2.22
  article-title: IL-2 simultaneously expands Foxp3+ T regulatory and T effector cells and confers resistance to severe tuberculosis (TB): implicative Treg-T effector cooperation in immunity to TB
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1101291
– ident: 2017011017160979000_jiw511v2.13
  doi: 10.1016/S1471-4906(03)00032-2
– ident: 2017011017160979000_jiw511v2.2
  doi: 10.1158/2326-6066.CIR-14-0201
– reference: 22422881 - J Immunol. 2012 Apr 15;188(8):3745-56
– reference: 25720636 - Immunobiology. 2015 Aug;220(8):947-53
– reference: 26361042 - PLoS One. 2015 Sep 11;10(9):e0136476
– reference: 22258246 - J Virol. 2012 Apr;86(8):4213-21
– reference: 24192393 - Physiol Genomics. 2013 Dec 15;45(24):1206-14
– reference: 22474020 - J Immunol. 2012 May 1;188(9):4278-88
– reference: 19325114 - Science. 2009 Mar 27;323(5922):1726-9
– reference: 11910108 - Science. 2002 Mar 22;295(5563):2255-8
– reference: 25184558 - Microbiol Mol Biol Rev. 2014 Sep;78(3):343-71
– reference: 21155952 - Genes Cells. 2011 Feb;16(2):179-89
– reference: 22342841 - Immunity. 2012 Feb 24;36(2):239-50
– reference: 24302476 - Stem Cells. 2014 May;32(5):1149-60
– reference: 17371987 - J Immunol. 2007 Apr 1;178(7):4304-14
– reference: 24316209 - Food Chem Toxicol. 2014 Feb;64:217-24
– reference: 8140422 - Science. 1994 Apr 1;264(5155):95-8
– reference: 26359984 - Cell. 2015 Sep 10;162(6):1242-56
– reference: 16337364 - Curr Opin Immunol. 2006 Feb;18(1):31-8
– reference: 18981295 - Blood. 2009 Jan 22;113(4):837-45
– reference: 24548303 - Cancer Invest. 2014 May;32(4):115-25
– reference: 25016223 - J Hepatol. 2014 Dec;61(6):1212-9
– reference: 23147720 - Cell Mol Immunol. 2013 Jan;10(1):58-64
– reference: 19229050 - Haematologica. 2009 Apr;94(4):576-80
– reference: 23661793 - J Infect Dis. 2013 Aug 15;208(4):603-15
– reference: 23144609 - PLoS Pathog. 2012;8(11):e1002984
– reference: 25141829 - Eur J Immunol. 2015 Feb;45(2):442-51
– reference: 18164222 - Immunity. 2008 Jan;28(1):29-39
– reference: 24643836 - Eur J Immunol. 2014 Jul;44(7):2013-24
– reference: 23770719 - Cell Immunol. 2013 Apr;282(2):106-12
– reference: 18811584 - J Infect Dis. 2008 Nov 15;198(10):1514-9
– reference: 11779458 - Cell. 2001 Dec 28;107(7):823-6
– reference: 25468804 - Cell Immunol. 2015 Jul;296(1):3-9
– reference: 21138378 - J Interferon Cytokine Res. 2011 Apr;31(4):363-71
– reference: 25701326 - Cancer Immunol Res. 2015 Jun;3(6):620-30
– reference: 10544201 - J Exp Med. 1999 Nov 1;190(9):1297-308
– reference: 19383786 - Proc Natl Acad Sci U S A. 2009 May 5;106(18):7553-8
– reference: 8627084 - J Infect Dis. 1996 May;173(5):1267-72
– reference: 20624978 - Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13402-7
– reference: 22269120 - Int J Immunogenet. 2012 Jun;39(3):247-52
– reference: 12697454 - Trends Immunol. 2003 Apr;24(4):213-9
– reference: 18266718 - Immunology. 2008 Jun;124(2):277-93
– reference: 25113973 - J Exp Med. 2014 Aug 25;211(9):1905-18
– reference: 21029966 - Immunity. 2010 Oct 29;33(4):567-77
– reference: 12447771 - J Infect Dis. 2002 Dec 15;186(12):1835-9
SSID ssj0004367
Score 2.3513808
Snippet A loss of antigen-specific T-cell responses due to defective cytokine signaling during infections has not been reported. We hypothesize that tuberculosis can...
Abstract A loss of antigen-specific T-cell responses due to defective cytokine signaling during infections has not been reported. We hypothesize that...
SourceID pubmedcentral
proquest
pubmed
crossref
oup
jstor
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 420
SubjectTerms Adult
Cell Proliferation
Female
Humans
Interleukin-2 - antagonists & inhibitors
Interleukin-2 - metabolism
Interleukin-23 - antagonists & inhibitors
Interleukin-23 - immunology
Latent Tuberculosis - immunology
Major
Male
Mycobacterium tuberculosis - immunology
Organophosphates - immunology
PATHOGENESIS AND HOST RESPONSE
Receptors, Antigen, T-Cell, gamma-delta
Signal Transduction
STAT3 Transcription Factor - metabolism
T-Lymphocyte Subsets - immunology
Title Selective Destruction of Interleukin 23–Induced Expansion of a Major Antigen–Specific γδ T-Cell Subset in Patients With Tuberculosis
URI https://www.jstor.org/stable/26166701
https://www.ncbi.nlm.nih.gov/pubmed/27789724
https://www.proquest.com/docview/1835692407
https://pubmed.ncbi.nlm.nih.gov/PMC5853380
Volume 215
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3djpNAFJ7UNRpvjK6u4l9mE9ebym6ZAQYutXZTNTUm2016R2AYLGuFpi3x5wF8A59En2OfyTM_UFrd-HNDCAwztN_HmcNwzncQegxziif8lNkOcRLbBdDtgIMxJIHHRJxQz1VBNKM3_vDUfTXxJp3Ot1bUUrVKDvmX3-aV_A-qcAxwlVmy_4Bs0ykcgH3AF7aAMGz_CuMTVcRGx_40QrB1cshiJqr3edEl1Jb1OeR3_sEnePaXpk3cHcVn5ULKB0hFTltVos9y3j3oDw6eU7V1u2O7L1f3pH0RqprAWy3EKuNmV9PuuErEglezcpkv237uOuPMiFLokK9qWX8Ralz5E5MeMiyLd0nZhANVil55Q91JHpd6mpzXk60MI8rr5e4p_LCpYbpZxAAu9JqAEFEbXmaDr0DblpnoTE9DQdqys67KoPvV_mttLDiUSoWG47P8o6dteYsN8w-KDoSxIGQ6gXtLcrs-dQldhl0iC2O8ePl6nW5LfWbkWmG8Iz3akR5Likubqzc8HR3supVF2XqZ2Y7JbTk54xvoukEMP9NUu4k6othFV3S90s-76OrIRGLcQl8b7uEW93CZ4Rb38Jp7uOGebBNjxT28zT18_v38B9acw5pzGLqpOYcl53Cbc7fR6fFg3B_apqaHzanHHFvETkqzmINnGMRuQgRj3EuJcDIn5G7mhlkMr9Ccix4JOU2cQKQJAz_L91nP4TGhe2inKAtxF2E3IEJqmTEvDV2udIcoF9BzwvzEczMLPa3__4gbwXtZd2UW6cALGmnkIo2chZ40zeda6eWihnsKzKYV8R11exbaB3T_dPF-jX0Ehlx-nYsLAY9fBHOr54dygcVCdzQX1iMYSlmIbbCkaSBF4jfPFPlUicV74I_ToHfvwj7vo2vrJ_IB2gHGiIfgaK-SR4r2PwGtcdkr
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Selective+Destruction+of+Interleukin+23-Induced+Expansion+of+a+Major+Antigen-Specific+%CE%B3%CE%B4+T-Cell+Subset+in+Patients+With+Tuberculosis&rft.jtitle=The+Journal+of+infectious+diseases&rft.au=Shen%2C+Hongbo&rft.au=Gu%2C+Jin&rft.au=Xiao%2C+Heping&rft.au=Liang%2C+Shanshan&rft.date=2017-02-01&rft.eissn=1537-6613&rft.volume=215&rft.issue=3&rft.spage=420&rft_id=info:doi/10.1093%2Finfdis%2Fjiw511&rft_id=info%3Apmid%2F27789724&rft.externalDocID=27789724
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1899&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1899&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1899&client=summon